This measure summary has been withdrawn from NQMC. Please update your bookmarks.
View all withdrawn summaries in the Measure Archive.
About NQMC Measure Summaries
New on NQMC
Myelodysplastic syndromes (MDS): percentage of MDS patients presenting with anemia who had a serum erythropoietin level less than or equal to 500 mU/ml prior to receiving erythropoietin/darbepoetin therapy.
New This Week
View more and sign up for our Newsletter